Exeltis USA, Inc., Laboratorios Leon Farma, S.a., Chemo Iberica, S.a., Chemo… v. Lupin Ltd., Lupin Pharmaceuticals, Inc.

25-1239Court of Appeals for the Federal Circuit29 de set. de 2025

Abrir fonte

Texto completo

NOTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
EXELTIS USA, INC., LABORATORIOS LEON
FARMA, S.A., CHEMO IBERICA, S.A., CHEMO
RESEARCH, S.L.,
Plaintiffs-Appellees
v.
LUPIN LTD., LUPIN PHARMACEUTICALS, INC.,
Defendants-Appellants
______________________
2025-1239
______________________
Appeal from the United States District Court for the
District of Delaware in No. 1:22-cv-00434-RGA, Judge
Richard G. Andrews.
______________________
ON MOTION
______________________
Before LOURIE, PROST, and CHEN, Circuit Judges.
PER CURIAM.
O R D E R
The parties notify the court that they have executed a
settlement agreement resolving all claims and move at
ECF Nos. 23 and 24 for dismissal of this appeal and
Case: 25-1239 Document: 25 Page: 1 Filed: 09/29/2025

-- 1 of 2 --

EXELTIS USA, INC. v. LUPIN LTD. 2
remand to the district court to amend the judgment con-
sistent with its August 29, 2025 indicative ruling.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) The motions are granted to the extent that the ap-
peal is remanded to the district court to rule on the parties’
motion to amend the final judgment, which this court
leaves to the district court. See Ohio Willow Wood Co. v.
Thermo-Ply, Inc., 629 F.3d 1374, 1375 (Fed. Cir. 2011).
(2) The parties shall bear their own costs.
September 29, 2025
Date
FOR THE COURT
ISSUED AS A MANDATE: September 29, 2025
Case: 25-1239 Document: 25 Page: 2 Filed: 09/29/2025

-- 2 of 2 --

Continue sua pesquisa no ChatGPT ou Claude

Conecte o Omnilex para pesquisar o corpus jurídico pelo seu assistente de IA.